CDKN1A and diabetic kidney disease: Preclinical evidence from DKD models also indicates that genes such as plasminogen activator inhibitor 1 (Pai1) and cyclin-dependent kinase inhibitor 1A (CDKN1A) are epigenetically regulated by TGF-β or high-glucose conditions in mesangial cells.